Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus in steroid refractory lupus nephritis
NCT00429377Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Jun 2003
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tacrolimus in lupus nephritis (LN), sponsored by Astellas Pharma. Started Jun 2003; status: completed.
02
Drugs
tacrolimus
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT00429377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00429377.